Johnson & Johnson (JNJ) Raw Materials (2012 - 2018)
Johnson & Johnson recorded quarterly Raw Materials of $1.1 billion in Q4 2018, down 7.32% quarter-over-quarter from $1.2 billion in Q3 2018, and down 2.28% year-over-year from $1.1 billion in Q4 2017.
Johnson & Johnson's Raw Materials history runs 6 years deep, the most recent figure standing at $1.1 billion for Q4 2018.
- In Q4 2018, Raw Materials fell 2.28% year-over-year to $1.1 billion; the TTM figure through Dec 2018 stood at $1.1 billion (down 2.28% YoY), while the FY2018 annual figure was $1.1 billion, down 2.28% from the prior year.
- Raw Materials came in at $1.1 billion for Q4 2018 at Johnson & Johnson, down from $1.2 billion in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $1.2 billion in Q4 2014 to a low of $936.0 million in Q1 2016.
- A 4-year average of $1.1 billion and a median of $1.1 billion in 2017 frame the typical range for Raw Materials.
- Across the five-year window, Raw Materials retreated 22.9% in 2016 and advanced 19.75% in 2017, its largest moves.
- Johnson & Johnson's Raw Materials stood at $1.2 billion in 2014, then retreated by 22.9% to $936.0 million in 2016, then grew by 21.79% to $1.1 billion in 2017, then decreased by 2.28% to $1.1 billion in 2018.
- According to Business Quant data, Raw Materials over the past three periods registered $1.1 billion, $1.2 billion, and $1.2 billion for Q4 2018, Q3 2018, and Q3 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2018 | 1.11 Bn |
| Sep 30, 2018 | 1.20 Bn |
| Jul 1, 2018 | 1.17 Bn |
| Dec 31, 2017 | 1.14 Bn |
| Jan 1, 2017 | 952.00 Mn |
| Jan 3, 2016 | 936.00 Mn |
| Dec 28, 2014 | 1.21 Bn |
| Dec 29, 2013 | 1.22 Bn |
| Dec 30, 2012 | 1.42 Bn |
| Jan 1, 2012 | 1.21 Bn |